TACE/ADAM17 Processing of EGFR Ligands Indicates a Role as a Physiological Convertase

By David C. Lee, S. Sunnarborg, C. Hinkle, T. Myers, Mary Stevenson, W. Russell, B. Castner, M. Gerhart, R. Paxton, R. Black and 2 more. 2003

193 citations recorded by the source corpus.

Subfields: Immunology and Allergy, Oncology, Radiology, Nuclear Medicine and Imaging

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. Carlos Fernandez-Patron
2. Pu Zhang
3. Mengcheng Shen
4. Z. Kassiri

Citations in the corpus

• ADAMs family and relatives in cardiovascular physiology and pathology. (2016, background): “Activation of Epidermal Growth Factor Receptor (EGFR), through shedding of membrane-anchored proTGFα [91] and proHB-EGF [92], has been identified among critical functions of ADAM17 [93–96], compared to other candidate HB-EGF sheddases (ADAM9, ADAM12 and ADAM15) [10,97].”
• Liver regeneration (2007, background): “TACE/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase.”